Dr. Anil Bhushan is currently a Professor at UCSF School of Medicine. After PhD studies at University of California, Davis, he did a fellowship at the Salk Institute of Biological Studies and Institute Curie in Paris. He was a principal investigator and faculty at UCLA before joining UCSF. He is the scientific founder of Deciduous Therapeutics, a startup developing immunotherapies for fibrotic and metabolic diseases.  His recent research interests revolve around stromal immune circuits in cancer and autoimmunity.